John Conner has been appointed senior vice president of GMP Manufacturing, Paragon Bioservices.

Mr. Conner has more than 30 years of experience serving as a biotechnology operation executive leading development in the areas of manufacturing, process development, analytical, manufacturing science and technology operations.   

Most recently, he served as senior vice president of operations at the start-up CDMO Cytovance Biologics, where he was responsible for building the operations team, manufacturing facilities and GMP systems for several biologic platforms. Prior to Cytovance, he served as associate director, Technical Support of CancerVax Corp., where he was responsible for technology transfer and the design, construction and operation of two biologics manufacturing facilities for clinical and commercial production.

“We are building a world class GMP team to complement the company’s preclinical capabilities. John’s experience and leadership in growing Cytovance and expanding its service offerings to include commercial manufacturing will be invaluable in supporting Paragon’s growth initiatives in GMP vaccine and gene-therapy viral vector manufacturing,” said Peter Buzy, president and chief executive officer of Paragon. “John’s experience is very broad and complements the wide array of biopharmaceuticals that we manufacture for our clients.  We are excited to have John join our senior team and to be a critical part of the Company’s future growth.”